NFKB1 and cancer: The importance of further characterisation of NF-κB expression in clinical cancer specimens is highlighted by the current efforts to develop novel drugs that inhibit NF-κB activation with the ultimate goal to use them for cancer treatment (Orlowski and Baldwin, 2002; Karin et al, 2004).